Back to search

France· FR:66743143

HELICOBACTER TEST INFAI pour les enfants agés de 3 à 11 ans, 45 mg, poudre pour solution buvable

A medicinal product containing urée [13c], registered in France by INFAI & NMR IMAGING (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedHELICOBACTER TEST INFAI pour les enfa…ATC—REGISTER NO.FR:66743143PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
URÉE [13C]
Manufacturer
INFAI & NMR IMAGING (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400938308600
    1 pot(s) polystyrène de 45 mg avec kit(s) de diagnostic(s)
    EUR 22.96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Urée [13c] in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urée [13c] products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Keratosis
  • Czechia · Excipial U Hydrolotio, Excipial U Lipolotio
  • Germany · Balisa, Basodexan
  • Denmark · Canoderm
  • Estonia · Linola
  • Spain · Urea Nm
  • Norway · Canoderm, Curemid
  • Sweden · Canoderm, Curemid
  • Slovenia · Linola
  • Slovakia · Excipial U Hydrolotio, Excipial U Lipolotio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/31edebf2-ab53-4882-80de-eb7a3618e5d3
GET /v1/drugs/31edebf2-ab53-4882-80de-eb7a3618e5d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66743143",
  "date_amm": "2002-10-10",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/97/045",
  "substance": "URÉE [13C]",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about urée [13c].

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.